Corvus Pharmaceuticals, Inc. (CRVS) Retained Earnings (Accumulated Deficit) USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Corvus Pharmaceuticals, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2015 to 2024.
  • Corvus Pharmaceuticals, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$340 M, a 7.88% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$340 M -$24.9 M -7.88% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$335 M -$27 M -8.79% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 -$328 M -$30.2 M -10.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$322 M -$39 M -13.8% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$316 M -$40.9 M -14.9% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 -$308 M -$41.3 M -15.5% Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$298 M -$40.7 M -15.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$283 M -$36.6 M -14.8% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$275 M -$40 M -17% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$266 M -$43.2 M -19.4% Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$257 M -$6.66 M -2.66% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 -$246 M -$5.78 M -2.4% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 -$235 M -$4.64 M -2.02% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 -$223 M -$6 M -2.76% Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$250 M -$44.4 M -21.5% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 -$241 M -$45.6 M -23.4% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 -$230 M -$48 M -26.3% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 -$217 M -$46.7 M -27.4% Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$206 M -$46.1 M -28.8% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 -$195 M -$45.6 M -30.5% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 -$182 M -$44.3 M -32.1% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$170 M -$46.9 M -38% Dec 31, 2018 10-K 2020-03-09
Q3 2018 -$160 M -$48.4 M -43.3% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 -$149 M -$50.6 M -51.1% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 -$138 M -$53.9 M -64.3% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 -$124 M -$55.7 M -82% Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$112 M -$54.8 M -96.5% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 -$98.9 M -$52.4 M -113% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 -$83.9 M -$46.1 M -122% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 -$67.9 M -$36.4 M -115% Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$56.8 M Sep 30, 2016 10-Q 2016-11-03
Q2 2016 -$46.5 M Jun 30, 2016 10-Q 2016-08-04
Q1 2016 -$37.8 M Mar 31, 2016 10-Q 2016-05-05
Q4 2015 -$31.5 M Dec 31, 2015 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.